In June 2003, an international group of scientists proposed the creation of a Global HIV Vaccine Enterprise. The authors invited discussion of this proposal, and challenged scientists to identify new strategies and mechanisms to accelerate the global effort to develop a safe and effective HIV vaccine. This paper describes the processes that led to agreement on the major roadblocks in HIV vaccine development, summarizes current scientific priorities, and describes an initial strategic approach to address those priorities. Specific research is not prescribed. Rather, the intent is to stimulate both researchers and funders to explore new, more collaborative, cooperative, and transparent approaches to address the major obstacles in HIV vaccine development identified in the plan, in addition to continuing the productive, high-quality programs already underway.
PLoS Med 2 (2): e25. doi:10.1371/journal.pmed.0020025
The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan